Gene Symbol | Gene ID | Gene Info |
---|---|---|
BARHL2
|
ENSG00000143032.7 | BarH like homeobox 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr1_91182648_91182861 | BARHL2 | 40 | 0.986842 | -0.86 | 3.1e-03 | Click! |
chr1_91191799_91191958 | BARHL2 | 9084 | 0.296600 | -0.79 | 1.1e-02 | Click! |
chr1_91188822_91188973 | BARHL2 | 6103 | 0.311405 | -0.79 | 1.1e-02 | Click! |
chr1_91195665_91195936 | BARHL2 | 13006 | 0.286355 | -0.79 | 1.2e-02 | Click! |
chr1_91195978_91196361 | BARHL2 | 13375 | 0.285510 | -0.78 | 1.2e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr14_101308246_101309004 | 3.19 |
ENSG00000214548 |
. |
7020 |
0.04 |
chr4_74527594_74528063 | 2.60 |
RASSF6 |
Ras association (RalGDS/AF-6) domain family member 6 |
41480 |
0.17 |
chr9_4137653_4137928 | 2.57 |
GLIS3 |
GLIS family zinc finger 3 |
7403 |
0.28 |
chr3_188139152_188139752 | 2.44 |
LPP-AS1 |
LPP antisense RNA 1 |
147002 |
0.04 |
chr7_115994446_115994930 | 2.34 |
ENSG00000216076 |
. |
8690 |
0.21 |
chr4_140958813_140959347 | 2.31 |
RP11-392B6.1 |
|
90089 |
0.09 |
chr1_234755566_234755985 | 2.27 |
IRF2BP2 |
interferon regulatory factor 2 binding protein 2 |
10504 |
0.19 |
chr5_67829635_67829905 | 2.18 |
PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
241374 |
0.02 |
chr17_80354102_80354437 | 2.16 |
RP13-20L14.4 |
|
4989 |
0.1 |
chr17_60074998_60075962 | 2.16 |
ENSG00000242398 |
. |
7868 |
0.17 |
chr16_24742094_24743166 | 2.07 |
TNRC6A |
trinucleotide repeat containing 6A |
1596 |
0.5 |
chrX_24073482_24074722 | 2.07 |
EIF2S3 |
eukaryotic translation initiation factor 2, subunit 3 gamma, 52kDa |
1014 |
0.57 |
chr7_17410528_17410788 | 2.00 |
ENSG00000199473 |
. |
2292 |
0.4 |
chr4_125861985_125862136 | 1.99 |
ANKRD50 |
ankyrin repeat domain 50 |
228173 |
0.02 |
chr2_47304732_47304883 | 1.93 |
AC073283.7 |
|
9846 |
0.2 |
chr3_152154396_152155165 | 1.90 |
ENSG00000201217 |
. |
12281 |
0.21 |
chr2_121370803_121371147 | 1.89 |
ENSG00000201006 |
. |
37874 |
0.21 |
chr5_77887462_77888069 | 1.85 |
LHFPL2 |
lipoma HMGIC fusion partner-like 2 |
42791 |
0.21 |
chr3_110133205_110133356 | 1.84 |
ENSG00000221206 |
. |
137532 |
0.05 |
chr7_134574979_134575413 | 1.76 |
CALD1 |
caldesmon 1 |
955 |
0.69 |
chr15_96817381_96817630 | 1.69 |
NR2F2-AS1 |
NR2F2 antisense RNA 1 |
1720 |
0.37 |
chr9_128521593_128522112 | 1.68 |
PBX3 |
pre-B-cell leukemia homeobox 3 |
11374 |
0.27 |
chr17_79378177_79378500 | 1.60 |
ENSG00000266392 |
. |
3760 |
0.14 |
chr8_98193900_98194199 | 1.59 |
KB-1958F4.1 |
|
37651 |
0.18 |
chr5_81460698_81461288 | 1.59 |
ENSG00000265684 |
. |
86747 |
0.08 |
chr12_10344371_10344522 | 1.57 |
TMEM52B |
transmembrane protein 52B |
12333 |
0.12 |
chr6_20877296_20877733 | 1.56 |
RP3-348I23.2 |
|
76589 |
0.12 |
chr3_37114880_37115172 | 1.56 |
LRRFIP2 |
leucine rich repeat (in FLII) interacting protein 2 |
10215 |
0.17 |
chr1_113067430_113067581 | 1.53 |
RP4-671G15.2 |
|
6442 |
0.19 |
chr4_119826460_119826775 | 1.52 |
SYNPO2 |
synaptopodin 2 |
16425 |
0.26 |
chr15_76176303_76176454 | 1.51 |
ENSG00000266308 |
. |
11003 |
0.15 |
chr1_44176337_44176618 | 1.49 |
KDM4A-AS1 |
KDM4A antisense RNA 1 |
2668 |
0.19 |
chr6_42192546_42192697 | 1.47 |
MRPS10 |
mitochondrial ribosomal protein S10 |
7018 |
0.19 |
chr13_59685015_59685166 | 1.47 |
ENSG00000239003 |
. |
369114 |
0.01 |
chr18_42871797_42872157 | 1.47 |
SLC14A2 |
solute carrier family 14 (urea transporter), member 2 |
79017 |
0.1 |
chr9_127458223_127458492 | 1.47 |
ENSG00000207737 |
. |
2368 |
0.24 |
chr22_20191302_20191696 | 1.47 |
XXbac-B444P24.8 |
|
942 |
0.46 |
chr4_95470032_95470452 | 1.46 |
PDLIM5 |
PDZ and LIM domain 5 |
25366 |
0.27 |
chr9_108061455_108061674 | 1.45 |
SLC44A1 |
solute carrier family 44 (choline transporter), member 1 |
54661 |
0.16 |
chr6_82476723_82477129 | 1.44 |
ENSG00000206886 |
. |
3185 |
0.27 |
chr8_129187891_129188042 | 1.40 |
ENSG00000221261 |
. |
25604 |
0.21 |
chr5_173958937_173959224 | 1.39 |
MSX2 |
msh homeobox 2 |
192456 |
0.03 |
chr5_158477621_158478266 | 1.38 |
EBF1 |
early B-cell factor 1 |
48758 |
0.14 |
chr10_31272970_31273270 | 1.38 |
ZNF438 |
zinc finger protein 438 |
235 |
0.96 |
chr2_216529775_216530114 | 1.37 |
ENSG00000212055 |
. |
213698 |
0.02 |
chr2_46326089_46326240 | 1.37 |
AC017006.2 |
|
20197 |
0.24 |
chr7_55142331_55142482 | 1.35 |
EGFR |
epidermal growth factor receptor |
35010 |
0.22 |
chr10_72592518_72593000 | 1.35 |
SGPL1 |
sphingosine-1-phosphate lyase 1 |
11495 |
0.2 |
chr15_90950843_90951750 | 1.35 |
RP11-154B12.3 |
|
10183 |
0.16 |
chr16_66933844_66934133 | 1.34 |
CDH16 |
cadherin 16, KSP-cadherin |
16311 |
0.09 |
chr15_71057979_71058253 | 1.34 |
UACA |
uveal autoantigen with coiled-coil domains and ankyrin repeats |
2184 |
0.33 |
chr17_40052012_40052163 | 1.34 |
ACLY |
ATP citrate lyase |
23117 |
0.1 |
chr15_71080718_71080869 | 1.34 |
RP11-138H8.3 |
|
9586 |
0.19 |
chr8_18591181_18591397 | 1.33 |
RP11-161I2.1 |
|
12874 |
0.25 |
chr12_105839590_105839741 | 1.33 |
C12orf75 |
chromosome 12 open reading frame 75 |
115019 |
0.06 |
chr2_220523539_220523690 | 1.33 |
SLC4A3 |
solute carrier family 4 (anion exchanger), member 3 |
27762 |
0.11 |
chr4_48332474_48332625 | 1.32 |
SLAIN2 |
SLAIN motif family, member 2 |
10790 |
0.24 |
chr6_74432714_74432936 | 1.32 |
RP11-553A21.3 |
|
26971 |
0.17 |
chr12_81231723_81232151 | 1.32 |
ENSG00000207763 |
. |
5529 |
0.25 |
chr3_159520081_159520232 | 1.31 |
ENSG00000252763 |
. |
6203 |
0.18 |
chr9_97567295_97567893 | 1.31 |
ENSG00000252153 |
. |
4650 |
0.2 |
chr15_49563917_49564068 | 1.30 |
GALK2 |
galactokinase 2 |
11911 |
0.23 |
chr4_142728522_142728673 | 1.30 |
IL15 |
interleukin 15 |
86295 |
0.11 |
chr8_38749440_38749591 | 1.29 |
PLEKHA2 |
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 2 |
9238 |
0.18 |
chr12_89339824_89340184 | 1.29 |
ENSG00000238302 |
. |
336058 |
0.01 |
chr2_66735450_66735818 | 1.28 |
MEIS1 |
Meis homeobox 1 |
425 |
0.88 |
chr5_80716815_80717031 | 1.27 |
ACOT12 |
acyl-CoA thioesterase 12 |
26925 |
0.22 |
chr8_105599662_105599940 | 1.27 |
LRP12 |
low density lipoprotein receptor-related protein 12 |
1433 |
0.43 |
chr15_60668644_60668795 | 1.27 |
ANXA2 |
annexin A2 |
2015 |
0.44 |
chr8_74282935_74283532 | 1.26 |
RP11-434I12.2 |
|
14537 |
0.25 |
chr3_185536101_185536453 | 1.25 |
IGF2BP2 |
insulin-like growth factor 2 mRNA binding protein 2 |
2572 |
0.33 |
chr5_81682860_81683011 | 1.25 |
ATP6AP1L |
ATPase, H+ transporting, lysosomal accessory protein 1-like |
81769 |
0.11 |
chr3_185536574_185536963 | 1.25 |
IGF2BP2 |
insulin-like growth factor 2 mRNA binding protein 2 |
2081 |
0.38 |
chr22_45865820_45865971 | 1.25 |
RP1-102D24.5 |
|
21271 |
0.16 |
chr10_60462562_60462713 | 1.24 |
BICC1 |
bicaudal C homolog 1 (Drosophila) |
90658 |
0.1 |
chr6_38230222_38230373 | 1.24 |
ENSG00000200706 |
. |
55247 |
0.15 |
chr22_46456526_46457258 | 1.23 |
RP6-109B7.3 |
|
6097 |
0.1 |
chr16_75045123_75045274 | 1.23 |
ZNRF1 |
zinc and ring finger 1, E3 ubiquitin protein ligase |
9003 |
0.21 |
chr3_114959246_114959397 | 1.23 |
ZBTB20 |
zinc finger and BTB domain containing 20 |
93203 |
0.1 |
chr10_127762727_127762878 | 1.23 |
ENSG00000222740 |
. |
71349 |
0.1 |
chr6_145388997_145389148 | 1.22 |
UTRN |
utrophin |
268555 |
0.02 |
chr11_9927954_9928253 | 1.22 |
ENSG00000252568 |
. |
62680 |
0.11 |
chr3_138581340_138581807 | 1.22 |
PIK3CB |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta |
27793 |
0.2 |
chr3_8531453_8531734 | 1.22 |
LMCD1-AS1 |
LMCD1 antisense RNA 1 (head to head) |
11691 |
0.21 |
chr4_22515546_22516022 | 1.21 |
GPR125 |
G protein-coupled receptor 125 |
1836 |
0.52 |
chr2_189540640_189540876 | 1.21 |
GULP1 |
GULP, engulfment adaptor PTB domain containing 1 |
105948 |
0.07 |
chr14_62031731_62032122 | 1.21 |
RP11-47I22.3 |
Uncharacterized protein |
5388 |
0.22 |
chr15_39438033_39438184 | 1.20 |
RP11-624L4.1 |
|
27194 |
0.25 |
chr1_31870163_31870721 | 1.20 |
SERINC2 |
serine incorporator 2 |
11970 |
0.15 |
chr2_96577379_96577638 | 1.20 |
ANKRD36C |
ankyrin repeat domain 36C |
15469 |
0.23 |
chr2_19985586_19985737 | 1.20 |
TTC32 |
tetratricopeptide repeat domain 32 |
115741 |
0.06 |
chr6_83665969_83666120 | 1.20 |
RP11-445L13__B.3 |
|
23724 |
0.24 |
chr8_16612044_16612195 | 1.20 |
ENSG00000264092 |
. |
108886 |
0.07 |
chr8_30362478_30362743 | 1.20 |
RBPMS |
RNA binding protein with multiple splicing |
62477 |
0.12 |
chr8_86847905_86848286 | 1.19 |
REXO1L10P |
REX1, RNA exonuclease 1 homolog (S. cerevisiae)-like 10, pseudogene |
89350 |
0.09 |
chr3_42085911_42086330 | 1.19 |
TRAK1 |
trafficking protein, kinesin binding 1 |
46442 |
0.16 |
chr13_111569474_111569747 | 1.18 |
ANKRD10 |
ankyrin repeat domain 10 |
2194 |
0.33 |
chr10_18955174_18955539 | 1.18 |
ARL5B |
ADP-ribosylation factor-like 5B |
7022 |
0.2 |
chr3_114082824_114082975 | 1.18 |
ZBTB20-AS1 |
ZBTB20 antisense RNA 1 |
2665 |
0.28 |
chr4_89491580_89491731 | 1.18 |
ENSG00000252322 |
. |
13468 |
0.16 |
chr3_99544339_99544531 | 1.18 |
CMSS1 |
cms1 ribosomal small subunit homolog (yeast) |
7754 |
0.24 |
chr12_14990014_14990290 | 1.17 |
RP11-233G1.4 |
|
3874 |
0.14 |
chr6_83778019_83778858 | 1.17 |
DOPEY1 |
dopey family member 1 |
1048 |
0.49 |
chr5_142016586_142016737 | 1.17 |
FGF1 |
fibroblast growth factor 1 (acidic) |
7105 |
0.22 |
chr3_171542852_171543133 | 1.16 |
PLD1 |
phospholipase D1, phosphatidylcholine-specific |
14708 |
0.17 |
chr2_65025641_65026023 | 1.16 |
ENSG00000239891 |
. |
18680 |
0.17 |
chr9_82676624_82676775 | 1.16 |
TLE4 |
transducin-like enhancer of split 4 (E(sp1) homolog, Drosophila) |
355018 |
0.01 |
chr10_63395536_63395687 | 1.16 |
C10orf107 |
chromosome 10 open reading frame 107 |
27108 |
0.22 |
chr3_27565967_27566162 | 1.16 |
ENSG00000201033 |
. |
10702 |
0.2 |
chr3_171930327_171930873 | 1.16 |
ENSG00000243398 |
. |
24516 |
0.22 |
chr6_121844212_121844363 | 1.16 |
ENSG00000201379 |
. |
19485 |
0.2 |
chr7_77425841_77426956 | 1.15 |
TMEM60 |
transmembrane protein 60 |
1499 |
0.34 |
chr8_105685859_105686010 | 1.15 |
ENSG00000263732 |
. |
81469 |
0.09 |
chr14_85883772_85884074 | 1.15 |
RP11-497E19.2 |
Uncharacterized protein |
111020 |
0.07 |
chr2_40612222_40612511 | 1.15 |
SLC8A1 |
solute carrier family 8 (sodium/calcium exchanger), member 1 |
45054 |
0.2 |
chr12_26471431_26471582 | 1.15 |
RP11-513G19.1 |
|
380 |
0.77 |
chr18_74188097_74188669 | 1.15 |
ZNF516 |
zinc finger protein 516 |
14352 |
0.17 |
chr3_177553335_177553655 | 1.14 |
ENSG00000199858 |
. |
172072 |
0.04 |
chr13_75343971_75344251 | 1.14 |
ENSG00000206812 |
. |
339613 |
0.01 |
chr18_65188248_65188399 | 1.14 |
DSEL |
dermatan sulfate epimerase-like |
4106 |
0.29 |
chr22_38795449_38796163 | 1.14 |
CSNK1E |
casein kinase 1, epsilon |
1279 |
0.34 |
chr4_152729350_152729501 | 1.14 |
PET112 |
PET112 homolog (yeast) |
47250 |
0.17 |
chr2_69253132_69253283 | 1.14 |
ANTXR1 |
anthrax toxin receptor 1 |
12678 |
0.21 |
chr10_115088662_115088813 | 1.14 |
ENSG00000238380 |
. |
24447 |
0.26 |
chr12_88896483_88896634 | 1.14 |
ENSG00000199245 |
. |
72339 |
0.11 |
chr4_184284303_184284454 | 1.14 |
ENSG00000263395 |
. |
21328 |
0.14 |
chr2_224683617_224683768 | 1.14 |
AP1S3 |
adaptor-related protein complex 1, sigma 3 subunit |
18509 |
0.26 |
chr4_174411560_174411794 | 1.14 |
HAND2-AS1 |
HAND2 antisense RNA 1 (head to head) |
36744 |
0.14 |
chr1_68638974_68639247 | 1.13 |
ENSG00000221203 |
. |
10183 |
0.22 |
chr8_37045608_37045759 | 1.13 |
KCNU1 |
potassium channel, subfamily U, member 1 |
259260 |
0.02 |
chr12_80325699_80326566 | 1.13 |
PPP1R12A |
protein phosphatase 1, regulatory subunit 12A |
2363 |
0.27 |
chr4_123685621_123686024 | 1.12 |
BBS12 |
Bardet-Biedl syndrome 12 |
31870 |
0.17 |
chr4_99535034_99535185 | 1.12 |
TSPAN5 |
tetraspanin 5 |
43677 |
0.16 |
chr15_96819224_96819500 | 1.12 |
NR2F2-AS1 |
NR2F2 antisense RNA 1 |
137 |
0.96 |
chr3_81776683_81776834 | 1.12 |
GBE1 |
glucan (1,4-alpha-), branching enzyme 1 |
16022 |
0.31 |
chr18_6730887_6731038 | 1.12 |
ARHGAP28 |
Rho GTPase activating protein 28 |
920 |
0.46 |
chr20_15637125_15637276 | 1.11 |
ENSG00000212111 |
. |
98087 |
0.08 |
chr7_14876837_14876988 | 1.11 |
DGKB |
diacylglycerol kinase, beta 90kDa |
4060 |
0.28 |
chr1_173822290_173822441 | 1.11 |
GAS5-AS1 |
GAS5 antisense RNA 1 |
10021 |
0.1 |
chr2_47346036_47346187 | 1.11 |
C2orf61 |
chromosome 2 open reading frame 61 |
32323 |
0.15 |
chr5_141998017_141998291 | 1.10 |
FGF1 |
fibroblast growth factor 1 (acidic) |
2753 |
0.29 |
chr11_33713061_33713264 | 1.10 |
RP4-541C22.5 |
|
5085 |
0.19 |
chr12_52585063_52585443 | 1.10 |
KRT80 |
keratin 80 |
531 |
0.69 |
chr13_34069291_34069442 | 1.10 |
STARD13 |
StAR-related lipid transfer (START) domain containing 13 |
144599 |
0.05 |
chr9_137395143_137395431 | 1.10 |
RXRA |
retinoid X receptor, alpha |
96859 |
0.07 |
chr3_101877143_101877294 | 1.10 |
ZPLD1 |
zona pellucida-like domain containing 1 |
59130 |
0.16 |
chr6_111273369_111273520 | 1.10 |
GTF3C6 |
general transcription factor IIIC, polypeptide 6, alpha 35kDa |
6319 |
0.15 |
chr4_146467395_146467619 | 1.10 |
SMAD1-AS1 |
SMAD1 antisense RNA 1 |
29237 |
0.17 |
chr11_33934050_33934291 | 1.10 |
LMO2 |
LIM domain only 2 (rhombotin-like 1) |
20334 |
0.2 |
chr5_10702719_10702870 | 1.09 |
CTD-2154B17.4 |
|
58383 |
0.12 |
chr7_55173223_55173374 | 1.09 |
EGFR |
epidermal growth factor receptor |
4118 |
0.33 |
chr12_26275796_26276929 | 1.09 |
SSPN |
sarcospan |
1438 |
0.31 |
chr2_12959099_12960371 | 1.09 |
ENSG00000264370 |
. |
82242 |
0.11 |
chr9_18479738_18479998 | 1.08 |
ADAMTSL1 |
ADAMTS-like 1 |
5637 |
0.32 |
chr7_101596544_101596695 | 1.08 |
CTB-181H17.1 |
|
6777 |
0.27 |
chr6_135679904_135680197 | 1.08 |
AHI1 |
Abelson helper integration site 1 |
52596 |
0.13 |
chr13_33836579_33836730 | 1.08 |
ENSG00000236581 |
. |
8862 |
0.23 |
chr11_9775679_9775937 | 1.07 |
SBF2-AS1 |
SBF2 antisense RNA 1 |
4031 |
0.21 |
chr2_145764381_145764532 | 1.07 |
ENSG00000253036 |
. |
328182 |
0.01 |
chr15_63070114_63070265 | 1.07 |
ENSG00000265317 |
. |
8817 |
0.19 |
chr2_225010185_225010480 | 1.07 |
ENSG00000211987 |
. |
93941 |
0.08 |
chr4_177929586_177929737 | 1.07 |
ENSG00000222859 |
. |
172935 |
0.03 |
chr12_56655589_56655740 | 1.07 |
ANKRD52 |
ankyrin repeat domain 52 |
3489 |
0.09 |
chr13_42387845_42387996 | 1.07 |
ENSG00000241406 |
. |
6107 |
0.29 |
chr14_52066426_52066577 | 1.07 |
ENSG00000251771 |
. |
5117 |
0.25 |
chr11_32078115_32078502 | 1.07 |
RP1-17K7.3 |
|
3502 |
0.18 |
chr3_119921549_119921940 | 1.06 |
ENSG00000206721 |
. |
7423 |
0.22 |
chr9_80110467_80110754 | 1.06 |
RP11-466A17.1 |
|
39399 |
0.2 |
chr17_66701651_66701802 | 1.06 |
ENSG00000263690 |
. |
60974 |
0.13 |
chr8_122166308_122166567 | 1.06 |
ENSG00000221644 |
. |
32695 |
0.23 |
chr3_47203435_47204414 | 1.06 |
SETD2 |
SET domain containing 2 |
1142 |
0.44 |
chr2_145237384_145237678 | 1.06 |
ZEB2 |
zinc finger E-box binding homeobox 2 |
37584 |
0.19 |
chr7_46949633_46949784 | 1.06 |
AC011294.3 |
Uncharacterized protein |
212988 |
0.03 |
chr10_21580851_21581002 | 1.05 |
ENSG00000207264 |
. |
29964 |
0.21 |
chr13_113258030_113258303 | 1.05 |
TUBGCP3 |
tubulin, gamma complex associated protein 3 |
15685 |
0.22 |
chr1_178434110_178434261 | 1.05 |
RASAL2 |
RAS protein activator like 2 |
12613 |
0.18 |
chr21_37859946_37860305 | 1.05 |
AP000695.1 |
|
1960 |
0.3 |
chr16_87840292_87840843 | 1.05 |
RP4-536B24.2 |
|
29571 |
0.14 |
chr5_9431807_9431958 | 1.05 |
SEMA5A |
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A |
51569 |
0.14 |
chr8_105689851_105690002 | 1.04 |
ENSG00000263732 |
. |
77477 |
0.1 |
chr5_158465704_158465855 | 1.04 |
CTD-2363C16.2 |
|
52965 |
0.13 |
chr17_6413687_6413838 | 1.04 |
PITPNM3 |
PITPNM family member 3 |
46018 |
0.11 |
chr10_54412447_54412741 | 1.04 |
RP11-556E13.1 |
|
91729 |
0.09 |
chr6_4370264_4370415 | 1.04 |
ENSG00000201185 |
. |
57858 |
0.15 |
chr4_47855204_47855355 | 1.04 |
CORIN |
corin, serine peptidase |
15156 |
0.2 |
chr8_104305968_104306122 | 1.04 |
RP11-318M2.2 |
|
4565 |
0.19 |
chr2_56071189_56071340 | 1.04 |
EFEMP1 |
EGF containing fibulin-like extracellular matrix protein 1 |
79092 |
0.09 |
chr2_204268978_204269129 | 1.03 |
ABI2 |
abl-interactor 2 |
13286 |
0.25 |
chr4_39525693_39526119 | 1.03 |
UGDH |
UDP-glucose 6-dehydrogenase |
2271 |
0.25 |
chr2_181486745_181486896 | 1.03 |
ENSG00000264976 |
. |
4887 |
0.36 |
chr9_118850395_118850653 | 1.03 |
PAPPA |
pregnancy-associated plasma protein A, pappalysin 1 |
65559 |
0.13 |
chr6_169971484_169971635 | 1.03 |
WDR27 |
WD repeat domain 27 |
89229 |
0.08 |
chr13_33766084_33766235 | 1.03 |
STARD13 |
StAR-related lipid transfer (START) domain containing 13 |
5943 |
0.25 |
chr3_188692042_188692831 | 1.03 |
TPRG1 |
tumor protein p63 regulated 1 |
27433 |
0.27 |
chr21_16433100_16433921 | 1.03 |
NRIP1 |
nuclear receptor interacting protein 1 |
3616 |
0.34 |
chr11_128685529_128685949 | 1.03 |
KCNJ1 |
potassium inwardly-rectifying channel, subfamily J, member 1 |
26690 |
0.17 |
chr2_237657369_237658039 | 1.03 |
ACKR3 |
atypical chemokine receptor 3 |
179420 |
0.03 |
chr11_130577176_130577327 | 1.02 |
C11orf44 |
chromosome 11 open reading frame 44 |
34400 |
0.23 |
chr10_22723256_22723780 | 1.02 |
RP11-301N24.3 |
|
73417 |
0.1 |
chr6_15349427_15349643 | 1.02 |
ENSG00000201519 |
. |
24832 |
0.19 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.3 | GO:0071692 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.8 | 3.2 | GO:0070141 | response to UV-A(GO:0070141) |
0.8 | 3.0 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.7 | 0.7 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.7 | 2.2 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.7 | 0.7 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.7 | 1.3 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.7 | 0.7 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.7 | 3.9 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.6 | 1.8 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) substrate-dependent cerebral cortex tangential migration(GO:0021825) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.6 | 4.3 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.6 | 1.8 | GO:0007132 | meiotic metaphase I(GO:0007132) |
0.6 | 3.6 | GO:0097061 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.6 | 2.4 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.6 | 4.0 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.6 | 1.7 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.6 | 1.7 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.6 | 1.7 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.6 | 0.6 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.5 | 0.5 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.5 | 2.1 | GO:0072311 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.5 | 2.1 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.5 | 1.5 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.5 | 2.0 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.5 | 2.0 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.5 | 1.5 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.5 | 1.4 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.5 | 1.9 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.5 | 1.9 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.5 | 1.9 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.4 | 0.9 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.4 | 0.9 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.4 | 0.9 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.4 | 2.1 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.4 | 2.0 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.4 | 1.2 | GO:0071436 | sodium ion export(GO:0071436) |
0.4 | 0.8 | GO:0042637 | catagen(GO:0042637) |
0.4 | 1.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.4 | 1.9 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.4 | 0.8 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.4 | 1.1 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.4 | 1.1 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.4 | 3.6 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.4 | 0.4 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.4 | 4.6 | GO:0035329 | hippo signaling(GO:0035329) |
0.4 | 1.1 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.3 | 2.0 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.3 | 1.3 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.3 | 0.6 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.3 | 2.2 | GO:0015871 | choline transport(GO:0015871) |
0.3 | 0.9 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.3 | 1.2 | GO:0002551 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
0.3 | 0.3 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.3 | 2.3 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.3 | 0.9 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.3 | 0.9 | GO:0008354 | germ cell migration(GO:0008354) |
0.3 | 1.1 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.3 | 2.8 | GO:0048844 | artery morphogenesis(GO:0048844) |
0.3 | 0.8 | GO:0010834 | obsolete telomere maintenance via telomere shortening(GO:0010834) |
0.3 | 1.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.3 | 1.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.3 | 0.3 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.3 | 5.2 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.3 | 1.9 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
0.3 | 6.7 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.3 | 1.9 | GO:1901532 | regulation of megakaryocyte differentiation(GO:0045652) regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.3 | 0.8 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) negative regulation of neural precursor cell proliferation(GO:2000178) |
0.3 | 1.6 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.3 | 0.3 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
0.3 | 0.5 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.3 | 0.8 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.3 | 0.8 | GO:0051832 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.3 | 1.0 | GO:0015889 | cobalamin transport(GO:0015889) |
0.3 | 0.5 | GO:0060900 | embryonic camera-type eye formation(GO:0060900) |
0.3 | 0.3 | GO:0071600 | otic vesicle formation(GO:0030916) otic vesicle development(GO:0071599) otic vesicle morphogenesis(GO:0071600) |
0.2 | 0.7 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.2 | 0.7 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.2 | 0.9 | GO:0034063 | stress granule assembly(GO:0034063) |
0.2 | 0.9 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.2 | 0.7 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.2 | 0.7 | GO:0034653 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.2 | 0.5 | GO:0051284 | negative regulation of ion transmembrane transporter activity(GO:0032413) negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) positive regulation of sequestering of calcium ion(GO:0051284) negative regulation of calcium ion transmembrane transport(GO:1903170) |
0.2 | 0.7 | GO:0018243 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.2 | 2.3 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.2 | 0.7 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.2 | 0.6 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) |
0.2 | 0.9 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.2 | 1.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.2 | 0.6 | GO:0010842 | retina layer formation(GO:0010842) |
0.2 | 0.6 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.2 | 1.2 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.2 | 0.4 | GO:0055094 | response to lipoprotein particle(GO:0055094) |
0.2 | 0.2 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) |
0.2 | 0.6 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.2 | 0.6 | GO:0060391 | regulation of SMAD protein import into nucleus(GO:0060390) positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.2 | 0.6 | GO:0001757 | somite specification(GO:0001757) |
0.2 | 0.4 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.2 | 0.2 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.2 | 0.2 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
0.2 | 0.2 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.2 | 0.2 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.2 | 0.4 | GO:0010193 | response to ozone(GO:0010193) |
0.2 | 0.2 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.2 | 0.4 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.2 | 0.9 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 0.2 | GO:0050955 | thermoception(GO:0050955) |
0.2 | 0.7 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.2 | 1.1 | GO:0008228 | opsonization(GO:0008228) |
0.2 | 0.4 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.2 | 0.7 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.2 | 0.5 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.2 | 2.0 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.2 | 0.7 | GO:0071320 | cellular response to cAMP(GO:0071320) |
0.2 | 0.5 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.2 | 1.8 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.2 | 0.7 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.2 | 0.4 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.2 | 0.4 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 0.4 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.2 | 0.5 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.2 | 0.5 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.2 | 0.9 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.2 | 0.3 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.2 | 1.5 | GO:0001759 | organ induction(GO:0001759) |
0.2 | 0.5 | GO:0048840 | otolith development(GO:0048840) |
0.2 | 1.0 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.2 | 0.3 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.2 | 0.7 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.2 | 0.5 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.2 | 0.3 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.2 | 0.7 | GO:0050926 | regulation of positive chemotaxis(GO:0050926) |
0.2 | 0.3 | GO:0003032 | detection of oxygen(GO:0003032) |
0.2 | 0.8 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.2 | 0.7 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 0.5 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.2 | 1.0 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.2 | 0.5 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.2 | 0.2 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.2 | 0.2 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
0.2 | 0.6 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.2 | 0.8 | GO:0009249 | protein lipoylation(GO:0009249) |
0.2 | 0.6 | GO:0002076 | osteoblast development(GO:0002076) |
0.2 | 0.9 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.2 | 1.5 | GO:0007567 | parturition(GO:0007567) |
0.2 | 0.6 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.2 | 0.8 | GO:0051133 | regulation of NK T cell activation(GO:0051133) positive regulation of NK T cell activation(GO:0051135) |
0.1 | 1.0 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.1 | 0.7 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) |
0.1 | 0.4 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.4 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.1 | 0.1 | GO:0042363 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.1 | 0.7 | GO:0000239 | pachytene(GO:0000239) |
0.1 | 0.4 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 1.2 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.1 | 0.4 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.4 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.1 | 2.0 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 0.4 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 0.3 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.1 | 0.3 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.1 | 0.6 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.1 | 0.6 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.1 | 1.0 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 0.3 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.6 | GO:0010560 | positive regulation of glycoprotein biosynthetic process(GO:0010560) positive regulation of glycoprotein metabolic process(GO:1903020) |
0.1 | 1.0 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 0.3 | GO:0014848 | urinary tract smooth muscle contraction(GO:0014848) |
0.1 | 0.3 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.1 | 0.3 | GO:0031076 | embryonic camera-type eye development(GO:0031076) |
0.1 | 0.4 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 1.1 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
0.1 | 0.4 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.1 | 0.5 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 1.0 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.1 | 0.4 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 1.7 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.1 | 0.8 | GO:0031641 | regulation of myelination(GO:0031641) |
0.1 | 0.6 | GO:0051883 | disruption of cells of other organism involved in symbiotic interaction(GO:0051818) killing of cells in other organism involved in symbiotic interaction(GO:0051883) |
0.1 | 0.1 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.1 | 0.4 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.1 | 0.3 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 2.1 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.1 | 0.1 | GO:0070254 | mucus secretion(GO:0070254) |
0.1 | 0.6 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.1 | 1.1 | GO:0000768 | syncytium formation by plasma membrane fusion(GO:0000768) |
0.1 | 0.2 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.1 | 0.1 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 0.1 | GO:1902224 | ketone body metabolic process(GO:1902224) |
0.1 | 1.5 | GO:0021772 | olfactory bulb development(GO:0021772) |
0.1 | 1.2 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.1 | 0.1 | GO:0060612 | adipose tissue development(GO:0060612) |
0.1 | 0.1 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.1 | 0.8 | GO:0007494 | midgut development(GO:0007494) |
0.1 | 0.7 | GO:0061082 | myeloid leukocyte cytokine production(GO:0061082) |
0.1 | 0.3 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 0.1 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.1 | 0.1 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.1 | 0.2 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.1 | 0.9 | GO:0000090 | mitotic anaphase(GO:0000090) |
0.1 | 0.3 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.2 | GO:0072677 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.1 | 0.2 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.3 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
0.1 | 0.6 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 0.4 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.1 | 0.4 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.1 | 0.2 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.1 | 0.3 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
0.1 | 0.2 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
0.1 | 0.2 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.1 | 0.2 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.1 | 0.2 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.1 | 0.4 | GO:0009414 | response to water deprivation(GO:0009414) response to water(GO:0009415) |
0.1 | 0.2 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 0.5 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.1 | 0.5 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.1 | 0.2 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 1.1 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.1 | 0.3 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.1 | 0.1 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.1 | 0.2 | GO:0072131 | kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
0.1 | 0.2 | GO:0050951 | sensory perception of temperature stimulus(GO:0050951) detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.3 | GO:0008049 | male courtship behavior(GO:0008049) |
0.1 | 0.4 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.4 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.1 | 0.4 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.1 | 0.2 | GO:1903521 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.1 | 0.1 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of pigment cell differentiation(GO:0050942) |
0.1 | 0.3 | GO:0006559 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.1 | 0.4 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.1 | 0.9 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 0.2 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.2 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.1 | 0.2 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.1 | 0.1 | GO:0061525 | hindgut morphogenesis(GO:0007442) hindgut development(GO:0061525) |
0.1 | 0.1 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
0.1 | 0.3 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.8 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 0.3 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.1 | 0.2 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.1 | 0.3 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.1 | 0.6 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
0.1 | 0.2 | GO:0019511 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.2 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.1 | 0.1 | GO:2000647 | negative regulation of stem cell proliferation(GO:2000647) |
0.1 | 0.5 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.4 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.1 | 0.3 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.5 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.3 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.1 | 0.4 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) pattern specification involved in metanephros development(GO:0072268) |
0.1 | 0.2 | GO:0071636 | positive regulation of transforming growth factor beta production(GO:0071636) |
0.1 | 0.2 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.1 | 0.5 | GO:0010896 | regulation of triglyceride catabolic process(GO:0010896) positive regulation of triglyceride catabolic process(GO:0010898) |
0.1 | 0.5 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 0.5 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.4 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.1 | 0.5 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.1 | 0.4 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.1 | 0.1 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 0.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.6 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.7 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.3 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.3 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.1 | 0.2 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
0.1 | 0.3 | GO:0001945 | lymph vessel development(GO:0001945) |
0.1 | 0.1 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.1 | 0.2 | GO:0035588 | adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.1 | 0.5 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.2 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 0.2 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.1 | 0.3 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.3 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.1 | 0.3 | GO:0006573 | valine metabolic process(GO:0006573) |
0.1 | 0.2 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.1 | 0.7 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.1 | 0.2 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 1.5 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
0.1 | 0.2 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.1 | 0.2 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 0.2 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.1 | 0.2 | GO:0044851 | hair cycle phase(GO:0044851) hair follicle maturation(GO:0048820) |
0.1 | 0.1 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.1 | 0.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.1 | GO:0060068 | vagina development(GO:0060068) |
0.1 | 0.2 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
0.1 | 0.6 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.1 | 0.2 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.1 | 0.2 | GO:0071025 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.1 | 0.2 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 0.2 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 0.2 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
0.1 | 0.4 | GO:0009200 | deoxyribonucleoside triphosphate metabolic process(GO:0009200) |
0.1 | 0.1 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.1 | 0.2 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 0.2 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.1 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.1 | 0.4 | GO:0010225 | response to UV-C(GO:0010225) |
0.1 | 0.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.2 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.1 | 0.3 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
0.1 | 0.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.1 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.1 | 2.9 | GO:0051291 | protein heterooligomerization(GO:0051291) |
0.1 | 0.3 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.1 | 0.4 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 0.1 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.1 | 0.1 | GO:0030728 | ovulation(GO:0030728) |
0.1 | 2.0 | GO:0001843 | neural tube closure(GO:0001843) |
0.1 | 0.2 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.1 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.1 | 0.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.2 | GO:0009130 | pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) |
0.1 | 0.2 | GO:0009074 | aromatic amino acid family catabolic process(GO:0009074) |
0.1 | 0.1 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.1 | 0.3 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.1 | 0.1 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.1 | 1.0 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.1 | 0.1 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.1 | 0.2 | GO:0060014 | granulosa cell differentiation(GO:0060014) |
0.1 | 0.1 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
0.1 | 0.1 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
0.1 | 0.1 | GO:0060996 | dendritic spine development(GO:0060996) |
0.1 | 0.2 | GO:0010799 | regulation of peptidyl-threonine phosphorylation(GO:0010799) positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 | 0.3 | GO:0015840 | urea transport(GO:0015840) |
0.1 | 0.2 | GO:0007412 | axon target recognition(GO:0007412) |
0.1 | 0.4 | GO:0006623 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
0.1 | 0.2 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.1 | 0.3 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.9 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.1 | 0.4 | GO:0006896 | Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
0.1 | 1.3 | GO:0043242 | negative regulation of protein complex disassembly(GO:0043242) |
0.1 | 0.1 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.1 | 0.1 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.2 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.2 | GO:0045002 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.1 | 0.4 | GO:0000726 | non-recombinational repair(GO:0000726) |
0.1 | 0.5 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.1 | 0.1 | GO:0003283 | atrial septum development(GO:0003283) atrial septum morphogenesis(GO:0060413) |
0.1 | 0.1 | GO:0006525 | arginine metabolic process(GO:0006525) |
0.1 | 0.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.2 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 0.2 | GO:0018101 | protein citrullination(GO:0018101) citrulline biosynthetic process(GO:0019240) |
0.1 | 0.2 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.1 | 0.1 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.1 | 0.3 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.1 | 0.1 | GO:0042160 | plasma lipoprotein particle oxidation(GO:0034441) regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.1 | 0.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 0.2 | GO:0016999 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.1 | 0.1 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.1 | 0.2 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.1 | 0.2 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.1 | GO:0072070 | loop of Henle development(GO:0072070) |
0.1 | 1.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.4 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 1.7 | GO:0017157 | regulation of exocytosis(GO:0017157) |
0.1 | 0.1 | GO:0060435 | bronchiole development(GO:0060435) |
0.1 | 0.8 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.1 | 0.1 | GO:0031659 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.1 | 0.1 | GO:0060457 | negative regulation of digestive system process(GO:0060457) |
0.1 | 0.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.3 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.1 | 0.1 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.1 | 0.1 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.1 | 0.2 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.1 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.1 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.2 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.0 | 0.2 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.0 | GO:0070295 | renal water absorption(GO:0070295) |
0.0 | 0.1 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.0 | 0.2 | GO:0016246 | RNA interference(GO:0016246) |
0.0 | 0.1 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.0 | 0.1 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
0.0 | 0.7 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.3 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 1.0 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.1 | GO:0060438 | trachea development(GO:0060438) |
0.0 | 0.1 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.0 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.6 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.0 | GO:0021910 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) |
0.0 | 0.1 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.0 | 0.4 | GO:0048286 | lung alveolus development(GO:0048286) |
0.0 | 0.1 | GO:0034723 | DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.0 | GO:0009651 | response to salt stress(GO:0009651) |
0.0 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.1 | GO:0070572 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.0 | 0.0 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.0 | 0.4 | GO:0006972 | hyperosmotic response(GO:0006972) |
0.0 | 0.2 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 0.3 | GO:0098764 | meiosis I cell cycle phase(GO:0098764) |
0.0 | 0.2 | GO:0046697 | decidualization(GO:0046697) |
0.0 | 0.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.0 | 0.2 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.0 | 0.6 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 0.2 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.0 | 0.1 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.0 | 0.2 | GO:0030539 | male genitalia development(GO:0030539) |
0.0 | 0.0 | GO:0014060 | regulation of epinephrine secretion(GO:0014060) |
0.0 | 0.4 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.7 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.1 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.3 | GO:0055010 | ventricular cardiac muscle tissue morphogenesis(GO:0055010) |
0.0 | 0.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.0 | 0.1 | GO:0009648 | photoperiodism(GO:0009648) |
0.0 | 0.1 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 0.1 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.0 | 0.2 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.0 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.0 | 1.3 | GO:0030198 | extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
0.0 | 0.2 | GO:0015858 | nucleoside transport(GO:0015858) |
0.0 | 0.2 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 | 0.1 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.0 | 0.6 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.0 | 0.1 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
0.0 | 0.3 | GO:0044247 | glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.0 | 0.1 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
0.0 | 0.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.1 | GO:0006693 | prostaglandin metabolic process(GO:0006693) |
0.0 | 0.5 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.2 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.0 | 0.1 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.0 | 0.4 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.1 | GO:0001820 | serotonin secretion(GO:0001820) |
0.0 | 0.3 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
0.0 | 0.2 | GO:0042438 | melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
0.0 | 0.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.0 | 0.1 | GO:0033189 | response to vitamin A(GO:0033189) |
0.0 | 0.0 | GO:0032049 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.0 | 0.1 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) |
0.0 | 0.1 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.0 | 0.1 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.0 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.0 | 0.1 | GO:0021932 | hindbrain radial glia guided cell migration(GO:0021932) |
0.0 | 0.1 | GO:0021898 | forebrain neuron fate commitment(GO:0021877) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.0 | 0.1 | GO:0043462 | regulation of ATPase activity(GO:0043462) |
0.0 | 0.1 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.0 | 0.0 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.0 | 0.2 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.0 | 0.4 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.0 | 0.2 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.0 | 0.1 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.0 | 0.2 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.0 | 0.1 | GO:0030239 | myofibril assembly(GO:0030239) |
0.0 | 0.0 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.0 | 0.0 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.0 | 0.1 | GO:0030033 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
0.0 | 0.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.0 | 0.0 | GO:0043113 | receptor clustering(GO:0043113) |
0.0 | 0.2 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) regulation of cellular response to insulin stimulus(GO:1900076) |
0.0 | 0.1 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.0 | 0.0 | GO:0032691 | negative regulation of interleukin-1 beta production(GO:0032691) |
0.0 | 0.2 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.0 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.0 | 0.0 | GO:0034694 | response to prostaglandin(GO:0034694) response to prostaglandin E(GO:0034695) |
0.0 | 0.1 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.0 | 0.0 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) meiotic chromosome separation(GO:0051307) |
0.0 | 0.0 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.0 | 0.0 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.0 | 0.0 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 0.1 | GO:0048144 | fibroblast proliferation(GO:0048144) |
0.0 | 0.0 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.0 | 0.1 | GO:0002040 | sprouting angiogenesis(GO:0002040) |
0.0 | 0.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.0 | GO:0044550 | secondary metabolite biosynthetic process(GO:0044550) |
0.0 | 0.1 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.0 | GO:0015791 | polyol transport(GO:0015791) |
0.0 | 0.1 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.0 | GO:0039656 | modulation by virus of host gene expression(GO:0039656) |
0.0 | 0.0 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.0 | 0.0 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.0 | 0.3 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.1 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.0 | 0.1 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.0 | 0.1 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.0 | GO:0043049 | otic placode formation(GO:0043049) |
0.0 | 0.1 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.0 | 0.1 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.1 | GO:0007350 | blastoderm segmentation(GO:0007350) |
0.0 | 0.0 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.0 | 0.0 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.0 | 0.2 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.0 | 1.2 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.4 | GO:0007588 | excretion(GO:0007588) |
0.0 | 0.0 | GO:0021903 | rostrocaudal neural tube patterning(GO:0021903) |
0.0 | 0.0 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.0 | 0.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.0 | 0.0 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
0.0 | 0.1 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.0 | GO:0055057 | neuronal stem cell division(GO:0036445) neuroblast division(GO:0055057) |
0.0 | 0.1 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.0 | 0.1 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.0 | 0.1 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.1 | GO:0051552 | flavone metabolic process(GO:0051552) |
0.0 | 0.0 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.0 | 0.0 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.0 | 0.1 | GO:0045598 | regulation of fat cell differentiation(GO:0045598) |
0.0 | 0.1 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.0 | 0.1 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.0 | 0.2 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.0 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.3 | GO:0007422 | peripheral nervous system development(GO:0007422) |
0.0 | 0.2 | GO:0030318 | melanocyte differentiation(GO:0030318) pigment cell differentiation(GO:0050931) |
0.0 | 1.5 | GO:0006936 | muscle contraction(GO:0006936) |
0.0 | 0.0 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.0 | 0.1 | GO:0001841 | neural tube formation(GO:0001841) |
0.0 | 0.1 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.0 | 0.1 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.0 | 0.0 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.0 | 0.3 | GO:0030336 | negative regulation of cell migration(GO:0030336) negative regulation of cell motility(GO:2000146) |
0.0 | 0.1 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.0 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
0.0 | 0.1 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.0 | 0.0 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.0 | 0.0 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
0.0 | 0.0 | GO:0021591 | ventricular system development(GO:0021591) |
0.0 | 0.0 | GO:0032891 | negative regulation of organic acid transport(GO:0032891) |
0.0 | 0.0 | GO:0071223 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.0 | 1.6 | GO:0006813 | potassium ion transport(GO:0006813) |
0.0 | 0.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.1 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.0 | 0.1 | GO:0070206 | protein trimerization(GO:0070206) |
0.0 | 0.1 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.1 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.6 | 1.3 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.6 | 1.7 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.6 | 1.7 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.5 | 2.0 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.4 | 2.2 | GO:0030056 | hemidesmosome(GO:0030056) |
0.4 | 1.3 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.4 | 3.0 | GO:0098642 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.4 | 2.5 | GO:0016342 | catenin complex(GO:0016342) |
0.4 | 3.1 | GO:0005614 | interstitial matrix(GO:0005614) |
0.4 | 3.1 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.4 | 2.8 | GO:0030128 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.3 | 2.4 | GO:0002102 | podosome(GO:0002102) |
0.3 | 0.9 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.3 | 0.3 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
0.3 | 1.1 | GO:0032059 | bleb(GO:0032059) |
0.3 | 1.5 | GO:0005916 | fascia adherens(GO:0005916) |
0.3 | 1.5 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.2 | 0.7 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 0.7 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.2 | 6.0 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.2 | 0.9 | GO:0033268 | node of Ranvier(GO:0033268) |
0.2 | 1.3 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 4.1 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 0.4 | GO:0043083 | synaptic cleft(GO:0043083) |
0.2 | 0.4 | GO:0014704 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.2 | 1.0 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.2 | 1.6 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.2 | 1.2 | GO:0001527 | microfibril(GO:0001527) |
0.2 | 0.8 | GO:0031512 | motile primary cilium(GO:0031512) |
0.2 | 1.0 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 1.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.2 | 2.2 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.2 | 0.5 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.2 | 0.9 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
0.2 | 0.5 | GO:0033646 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.2 | 0.8 | GO:0030870 | Mre11 complex(GO:0030870) |
0.2 | 0.6 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.2 | 1.4 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.2 | 0.8 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.1 | 0.6 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.1 | 0.7 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 1.4 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 2.1 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 1.1 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.5 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 0.5 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.8 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 11.2 | GO:0030016 | myofibril(GO:0030016) |
0.1 | 3.0 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 0.4 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.2 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 0.9 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.5 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 0.1 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 25.7 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 0.5 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 0.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.4 | GO:0036126 | outer dense fiber(GO:0001520) sperm flagellum(GO:0036126) |
0.1 | 3.7 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 1.3 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.6 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 0.7 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 0.2 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.1 | 0.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.6 | GO:0030677 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.1 | 0.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.6 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 0.3 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 0.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.2 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
0.1 | 4.2 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.1 | 1.6 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 0.5 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.2 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.1 | 0.2 | GO:0031083 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
0.1 | 0.1 | GO:0032432 | actin filament bundle(GO:0032432) |
0.1 | 3.1 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 1.5 | GO:0098636 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.1 | 0.3 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 2.6 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 0.4 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.4 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 2.8 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.4 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.4 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.4 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.2 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 0.5 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.8 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.2 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 1.4 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.0 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 1.6 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.1 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.2 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.0 | 0.3 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.0 | 0.0 | GO:0060076 | excitatory synapse(GO:0060076) |
0.0 | 2.8 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.2 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 0.4 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.0 | 0.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.6 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.1 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 0.2 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.1 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.5 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.1 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 0.0 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.0 | 1.6 | GO:0005923 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.0 | 0.0 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.0 | 0.7 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 0.0 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.2 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.0 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.1 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 1.4 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.0 | 0.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.1 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.6 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 1.1 | GO:0005912 | adherens junction(GO:0005912) |
0.0 | 1.0 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.1 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.0 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.0 | 0.1 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.0 | 0.0 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 0.3 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.0 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.9 | GO:0016324 | apical plasma membrane(GO:0016324) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 4.0 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
1.2 | 3.6 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
1.1 | 4.3 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
1.0 | 3.0 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.7 | 2.2 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) |
0.6 | 2.4 | GO:0042805 | actinin binding(GO:0042805) |
0.6 | 2.4 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.6 | 1.8 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.5 | 4.3 | GO:0017166 | vinculin binding(GO:0017166) |
0.5 | 1.5 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.5 | 1.5 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.5 | 1.8 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.4 | 1.3 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.4 | 1.2 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.4 | 1.6 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.4 | 1.6 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.4 | 1.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.4 | 2.4 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
0.4 | 1.5 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.4 | 1.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.4 | 1.1 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.4 | 1.1 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.4 | 1.4 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.3 | 1.4 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.3 | 4.7 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.3 | 2.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.3 | 3.0 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.3 | 2.3 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.3 | 1.0 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.3 | 1.6 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 0.9 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.3 | 1.9 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.3 | 1.3 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.3 | 1.3 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.3 | 0.9 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.3 | 1.8 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.3 | 1.7 | GO:0030274 | LIM domain binding(GO:0030274) |
0.3 | 2.0 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.3 | 1.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.3 | 3.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.3 | 1.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.3 | 1.3 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.3 | 1.0 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.3 | 1.0 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.3 | 1.6 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.3 | 1.5 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 1.2 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.2 | 1.0 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 1.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.2 | 0.7 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 0.9 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.2 | 0.2 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.2 | 3.7 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.2 | 1.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.2 | 0.6 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.2 | 0.6 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 0.6 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.2 | 2.5 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.2 | 0.2 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.2 | 0.6 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 1.4 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.2 | 0.6 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.2 | 4.1 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.2 | 0.4 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.2 | 1.0 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.2 | 0.8 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.2 | 0.6 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 0.8 | GO:0032190 | acrosin binding(GO:0032190) |
0.2 | 0.5 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.2 | 0.2 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.2 | 0.5 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.2 | 1.6 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 0.7 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.2 | 11.1 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.2 | 0.8 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.2 | 0.5 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 0.7 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 0.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 0.7 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.2 | 0.5 | GO:0035514 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.2 | 1.6 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.2 | 0.5 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.2 | 0.5 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.2 | 1.5 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.1 | 0.4 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.4 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 1.0 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 1.0 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 0.4 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 0.4 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 0.9 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 1.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.6 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 1.0 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 0.1 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.4 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.4 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 1.2 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.4 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.4 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 0.8 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.4 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.1 | 0.5 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 6.3 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.1 | 0.5 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 0.6 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.4 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.1 | 1.9 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 2.6 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 0.3 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.5 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.1 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.1 | 0.6 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.9 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.1 | 0.2 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.5 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 1.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.7 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.4 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.1 | 0.6 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.1 | 0.7 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.1 | 0.6 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 1.0 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.5 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 1.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.2 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.1 | 0.3 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 1.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.7 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.1 | 0.2 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.1 | 0.3 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.3 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.1 | 0.3 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.1 | 1.8 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.1 | 0.6 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.1 | 0.7 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 1.6 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 0.7 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 0.5 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 0.3 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.1 | 0.7 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.1 | 0.3 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 0.3 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 0.2 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.1 | 0.3 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.8 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.4 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.3 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.1 | 0.3 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 0.3 | GO:0003896 | DNA primase activity(GO:0003896) |
0.1 | 0.4 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.3 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 0.3 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 0.4 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.1 | 1.1 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 2.0 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 0.3 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.1 | 0.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 0.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.9 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 1.0 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 1.0 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 1.1 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 0.7 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.1 | 0.2 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.2 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.1 | 3.7 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 0.3 | GO:0016847 | 1-aminocyclopropane-1-carboxylate synthase activity(GO:0016847) |
0.1 | 0.6 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 0.4 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.3 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.1 | 0.5 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.3 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.1 | 0.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 0.1 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.1 | 0.6 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 0.2 | GO:0019798 | procollagen-proline 3-dioxygenase activity(GO:0019797) procollagen-proline dioxygenase activity(GO:0019798) peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.1 | 1.0 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.1 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 0.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.6 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.1 | 0.6 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 0.4 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 3.2 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 0.5 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.3 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 0.3 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 0.3 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.1 | 0.3 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.2 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.1 | 0.3 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 0.3 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.1 | 0.8 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.1 | 0.5 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 0.4 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 0.9 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.1 | 0.9 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 0.3 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.1 | 0.4 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.1 | 0.1 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.1 | 0.1 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.1 | 0.3 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.1 | 0.2 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 0.1 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) |
0.1 | 0.1 | GO:0000404 | heteroduplex DNA loop binding(GO:0000404) |
0.1 | 0.6 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.2 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 0.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.3 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.1 | 0.1 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 0.2 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.1 | 0.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.5 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.1 | 0.1 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.1 | 0.5 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 4.1 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.1 | 0.1 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) L-cystine transmembrane transporter activity(GO:0015184) |
0.1 | 0.9 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.5 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.3 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.0 | 0.2 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.0 | 0.4 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.4 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.0 | 0.0 | GO:0047115 | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity(GO:0047115) |
0.0 | 0.0 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
0.0 | 1.1 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 2.3 | GO:0005254 | chloride channel activity(GO:0005254) |
0.0 | 0.2 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.1 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.0 | 0.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 0.3 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.9 | GO:0005272 | sodium channel activity(GO:0005272) |
0.0 | 3.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.2 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.2 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 0.3 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.3 | GO:0048185 | activin binding(GO:0048185) |
0.0 | 0.4 | GO:0051378 | serotonin binding(GO:0051378) |
0.0 | 0.8 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 1.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.1 | GO:0004803 | transposase activity(GO:0004803) |
0.0 | 0.0 | GO:0016411 | acylglycerol O-acyltransferase activity(GO:0016411) |
0.0 | 0.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.6 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.0 | 0.2 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.0 | 0.3 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 0.1 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.0 | 0.3 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.2 | GO:0044390 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.0 | 0.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.0 | 0.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.0 | 0.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 0.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 0.1 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.1 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
0.0 | 0.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.1 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.0 | 0.1 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.0 | 0.1 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.0 | 0.1 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.0 | 3.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.0 | 0.1 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.1 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 0.2 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 0.1 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.3 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.1 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.0 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.0 | 0.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.1 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.1 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.0 | 0.2 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.1 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.0 | 0.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.3 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.1 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.0 | 0.2 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.2 | GO:0015250 | water transmembrane transporter activity(GO:0005372) water channel activity(GO:0015250) |
0.0 | 0.1 | GO:0030354 | melanin-concentrating hormone activity(GO:0030354) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.1 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.0 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 0.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.4 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.0 | 0.0 | GO:0030172 | troponin C binding(GO:0030172) |
0.0 | 0.2 | GO:0034595 | phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
0.0 | 0.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.0 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.1 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.0 | 0.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.1 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.0 | 0.0 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.1 | GO:0008199 | ferric iron binding(GO:0008199) |
0.0 | 0.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.0 | 0.1 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.0 | 1.9 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 0.1 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.0 | 0.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.0 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.0 | 0.0 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.0 | 0.3 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.0 | GO:0009374 | biotin binding(GO:0009374) |
0.0 | 0.1 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.1 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.2 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.0 | 0.3 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.4 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.1 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 0.0 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.0 | 0.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.1 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.1 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.1 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.1 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.0 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.1 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.0 | GO:0016151 | nickel cation binding(GO:0016151) |
0.0 | 0.1 | GO:0001972 | retinoic acid binding(GO:0001972) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 0.8 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.4 | 5.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.3 | 5.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.3 | 13.0 | NABA COLLAGENS | Genes encoding collagen proteins |
0.3 | 2.8 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 3.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 3.5 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.2 | 0.6 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 0.9 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 0.3 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 4.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 20.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 0.9 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 3.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.6 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 0.2 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 0.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 0.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 1.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 0.3 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 2.5 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 0.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 0.7 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 0.5 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.2 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 1.0 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 2.1 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 13.2 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.9 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.3 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 1.0 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 0.0 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.0 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.8 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.4 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 1.0 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 1.2 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 5.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.0 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.6 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.3 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 0.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.6 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 1.9 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.8 | 0.8 | REACTOME PHOSPHOLIPASE C MEDIATED CASCADE | Genes involved in Phospholipase C-mediated cascade |
0.5 | 0.5 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.5 | 4.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.4 | 9.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.4 | 0.4 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.4 | 3.7 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.3 | 4.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.3 | 8.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.2 | 12.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 2.5 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.2 | 1.4 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.2 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.2 | 1.8 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.2 | 1.9 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.2 | 1.7 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 2.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.0 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 0.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 0.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 1.6 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 1.1 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.1 | 0.1 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 0.9 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 1.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 0.7 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 2.8 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 0.7 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 3.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 1.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 2.1 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 1.6 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.1 | 0.3 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.1 | 0.1 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.1 | 1.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 0.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 2.6 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.1 | 0.6 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.1 | 0.6 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.7 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 2.0 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 1.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 1.6 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 1.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 1.1 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.1 | 1.0 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.1 | 1.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.7 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 0.6 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 0.6 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 0.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 1.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 0.7 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 0.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 0.1 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.1 | 0.2 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 0.6 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 1.2 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 0.9 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 0.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.6 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.3 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 1.0 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.2 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.3 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.1 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.0 | 0.5 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.5 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 1.3 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 0.2 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 1.1 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 1.0 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.0 | 0.5 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.0 | 0.4 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 2.7 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.9 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.5 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 1.7 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.4 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.0 | 0.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.4 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.0 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.0 | 0.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.2 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.0 | 0.4 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.5 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.0 | 0.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.1 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
0.0 | 0.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.3 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 0.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.3 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 0.2 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.1 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.2 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.1 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.0 | 0.0 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.0 | 0.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.1 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.6 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |